Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland 21201; Surgery, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland 21201; the Departments of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
J Biol Chem. 2011 Sep 2;286(35):30535-30541. doi: 10.1074/jbc.M111.265413. Epub 2011 Jun 15.
The LDL receptor-related protein 1 (LRP1) is a large endocytic receptor that controls macrophage migration in part by interacting with β(2) integrin receptors. However, the molecular mechanism underlying LRP1 integrin recognition is poorly understood. Here, we report that LRP1 specifically recognizes α(M)β(2) but not its homologous receptor α(L)β(2). The interaction between these two cellular receptors in macrophages is significantly enhanced upon α(M)β(2) activation by LPS and is mediated by multiple regions in both LRP1 and α(M)β(2). Specifically, we find that both the heavy and light chains of LRP1 are involved in α(M)β(2) binding. Within the heavy chain, the binding is mediated primarily via the second and fourth ligand binding repeats. For α(M)β(2), we find that the α(M)-I domain represents a major LRP1 recognition site. Indeed, substitution of the I domain of the α(L)β(2) receptor with that of α(M) confers the α(L)β(2) receptor with the ability to interact with LRP1. Furthermore, we show that residues (160)EQLKKSKTL(170) within the α(M)-I domain represent a major LRP1 recognition site. Given that perturbation of this specific sequence leads to altered adhesive activity of α(M)β(2), our finding suggests that binding of LRP1 to α(M)β(2) could alter integrin function. Indeed, we further demonstrate that the soluble form of LRP1 (sLRP1) inhibits α(M)β(2)-mediated adhesion of cells to fibrinogen. These studies suggest that sLRP1 may attenuate inflammation by modulating integrin function.
低密度脂蛋白受体相关蛋白 1(LRP1)是一种大型内吞受体,通过与β(2)整合素受体相互作用来控制巨噬细胞迁移。然而,LRP1 整合素识别的分子机制尚不清楚。在这里,我们报告 LRP1 特异性识别α(M)β(2),但不识别其同源受体α(L)β(2)。在巨噬细胞中,这两种细胞受体之间的相互作用在 LPS 激活α(M)β(2)后显著增强,并由 LRP1 和α(M)β(2)中的多个区域介导。具体而言,我们发现 LRP1 的重链和轻链都参与了α(M)β(2)的结合。在重链中,结合主要通过第二和第四个配体结合重复介导。对于α(M)β(2),我们发现 LRP1 的重链主要通过α(M)I 结构域识别。事实上,用α(M)I 结构域取代α(L)β(2)受体的 I 结构域赋予了α(L)β(2)受体与 LRP1 相互作用的能力。此外,我们发现α(M)I 结构域内的残基(160)EQLKKSKTL(170)是 LRP1 的主要识别位点。鉴于该特定序列的扰动会导致α(M)β(2)的粘附活性改变,我们的发现表明 LRP1 与α(M)β(2)的结合可能改变整合素功能。事实上,我们进一步证明 LRP1 的可溶性形式(sLRP1)抑制了细胞与纤维蛋白原之间的α(M)β(2)介导的粘附。这些研究表明,sLRP1 通过调节整合素功能可能减轻炎症。